91616-41-0

Basic information

• Product Name: 1H-Tetrazole-5-carboxylicacid,1-methyl-,ethylester(9CI)
• Synonyms: 1H-Tetrazole-5-carboxylicacid,1-methyl-,ethylester(9CI);1-METHYL-1H-TETRAZOLE-5-CARBOXYLIC ACID ETHYL ESTER
• CAS NO: 91616-41-0
• Molecular Formula: C₅H₈N₄O₂
• Molecular Weight: 156.14
• Product Categories: GLYCINESCAFFOLD
• Mol File: 91616-41-0.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1H-Tetrazole-5-carboxylicacid,1-methyl-,ethylester(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Tetrazole-5-carboxylicacid,1-methyl-,ethylester(9CI)(91616-41-0)
• EPA Substance Registry System: 1H-Tetrazole-5-carboxylicacid,1-methyl-,ethylester(9CI)(91616-41-0)

Safety Data

• Hazardous Substances Data: 91616-41-0(Hazardous Substances Data)

Upstream product

• 55408-10-1 1H-tetrazole-5-carboxylic acid ethyl ester 
• 74-88-4 methyl iodide 

Downstream Products

• 136622-10-1 3-<3-(piperidinomethyl)phenoxy>-N-(1-methyl-1H-tetrazol-5-ylcarbonyl)propanamine 
• 13175-00-3 2-methyl-2H-1,2,3,4-tetrazole-5-carboxylic acid 
• 77689-87-3 1-methyl-1H-tetrazole-5-carboxylic acid 
• 1707562-96-6 (1-methyl-1H-tetrazol-5-yl)methanol 

Relevant articles and documents

SMALL MOLECULE MODULATORS OF IL-17

The present invention relates to a compound according to formula (I), (I) and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.

DIHYDROBENZOFURAN AND INDEN ANALOGS AS CARDIAC SARCOMERE INHIBITORS

Provided are compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein A, Z, B, R1, R2, R3, G1, G2, and G3 are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (I), or a pharmaceutically acceptable salt thereof Also provided are methods of using a compound of Formula (I), or a pharmaceutically acceptable salt, thereof for use in methods of treatment heart diseases through cardiac sarcomere inhibtion.

QUINOLONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS

The present invention relates to novel quinolones of Formula I that inhibit inducible NOS synthase together with methods of synthesizing and using the compounds including methods for inhibiting or modulating nitric oxide synthesis and/or lowering nitric oxide levels in a patient by administering the compounds for the treatment of disease.